More News
1 November 2013
Ignyta Completes Merger and Announces License Agreement for the Development of Two Leading Tyrosine Kinase Inhibitors31 October 2013
Fidelity Biosciences and REGENX Biosciences Launch Dimension Therapeutics to Develop and Commercialize Novel AAV Gene Therapy Products31 October 2013
ZoBio and Actelion Enter into Drug Discovery Collaboration31 October 2013
Lead Discovery Center GmbH Announces Five-year Strategic Partnership with Merck Serono30 October 2013
Teva Announces Departure of President and CEO28 October 2013
EMD Serono and Open Monoclonal Technology Expand Collaboration to Include Unlimited Access to OmniRat® Human Antibody Platform28 October 2013
BELLUS Health and AmorChem Announce a Partnership to Develop Drug Candidates for AL Amyloidosis19 October 2013
ABLYNX SIGNS EXCLUSIVE LICENSE AGREEMENT WITH EDDINGPHARM TO DEVELOP AND COMMERCIALISE ITS ANTI-RANKL NANOBODY IN GREATER CHINA19 October 2013
Stallergenes and DBV Technologies Announce Respiratory Allergy Research and Development Collaboration for Birch Pollen17 October 2013
AmpliPhi Signs Exclusive License With University of Leicester, UK to Develop Bacteriophage Therapies Targeting C. Difficile17 October 2013
TARIS Biomedical® Enters Research Collaboration with AstraZeneca for Improved Bladder Cancer Treatments16 October 2013
Zydus and Pieris Sign Broad Co-Development Alliance for Novel Anticalin® Therapeutics15 October 2013
PolyTherics and TUBE Pharma collaborate to develop novel cytotoxic payloads for antibody drug conjugates (ADCs)15 October 2013
AstraZeneca oncology portfolio strengthened as MedImmune acquisition of Spirogen boosts antibody-drug conjugate capability14 October 2013
Roche to invest 800 million Swiss francs in global biologic medicine manufacturing network14 October 2013
SAFC® Invests in Commercial-Scale ADC Conjugation Manufacturing and Services; Expands HPAPI Manufacturing and Storage Capacity14 October 2013
BioInvent and Bayer extend and broaden collaboration for the discovery and development of therapeutic antibodies13 October 2013
Cancer Therapy Collaboration with LillyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports